Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo
Abstract Solid organ transplantation is a lifesaving therapy for patients with end-organ disease. Current immunosuppression protocols are not designed to target antigen-specific alloimmunity and are uncapable of preventing chronic allograft injury. As myeloid-derived suppressor cells (MDSCs) are pot...
Main Authors: | Songjie Cai, John Y. Choi, Thiago J. Borges, Hengcheng Zhang, Ji Miao, Takaharu Ichimura, Xiaofei Li, Simiao Xu, Philip Chu, Siawosh K. Eskandari, Hazim Allos, Juliano B. Alhaddad, Saif A. Muhsin, Karim Yatim, Leonardo V. Riella, Peter T. Sage, Anil K. Chandraker, Jamil R. Azzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-71289-z |
Similar Items
-
The change of myeloid-derived suppressor cells(MDSCs) following chemotherapy
by: Chang, Chun-Hsiang, et al.
Published: (2015) -
Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
by: Xidan Gao, et al.
Published: (2021-02-01) -
Evolution of our understanding of myeloid regulatory cells: from MDSCs to Mregs
by: Masoud H Manjili, et al.
Published: (2014-07-01) -
Gene expression profiling of human fibrocytic myeloid-derived suppressor cells (f-MDSCs)
by: Emilia Maria Cristina Mazza, et al.
Published: (2014-12-01) -
The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
by: Christos Demosthenous, et al.
Published: (2021-05-01)